Cellebrite Di Ltd. (CLBT)

$13.98

+0.28

(+2.01%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $13.86
    $14.04
    $13.98
    downward going graph

    0.86%

    Downside

    Day's Volatility :1.27%

    Upside

    0.41%

    downward going graph
  • $6.37
    $13.98
    $13.98
    downward going graph

    54.43%

    Downside

    52 Weeks Volatility :54.43%

    Upside

    0.0%

    downward going graph

Returns

PeriodCellebrite Di Ltd.Sector (Technology)Index (Russel 2000)
3 Months
25.92%
6.9%
0.0%
6 Months
48.11%
5.9%
0.0%
1 Year
77.69%
21.3%
0.0%
3 Years
33.66%
38.3%
-20.2%

Highlights

Market Capitalization
2.7B
Book Value
- $0.14
Earnings Per Share (EPS)
-0.58
Wall Street Target Price
14.42
Profit Margin
-33.98%
Operating Margin TTM
10.2%
Return On Assets TTM
5.58%
Return On Equity TTM
-1768.51%
Revenue TTM
329.2M
Revenue Per Share TTM
1.71
Quarterly Revenue Growth YOY
25.900000000000002%
Gross Profit TTM
219.9M
EBITDA
52.8M
Diluted Eps TTM
-0.58
Quarterly Earnings Growth YOY
-0.77
EPS Estimate Current Year
0.33
EPS Estimate Next Year
0.41
EPS Estimate Current Quarter
0.05
EPS Estimate Next Quarter
0.07

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Cellebrite Di Ltd.(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
10
Hold
1
1
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 3.15%

Current $13.98
Target $14.42

Company Financials

FY19Y/Y Change
Revenue
171.9M
-
Net Income
-1.9M
-
Net Profit Margin
-1.09%
-
FY20Y/Y Change
Revenue
194.9M
↑ 13.42%
Net Income
5.8M
↓ 408.16%
Net Profit Margin
2.97%
↑ 4.06%
FY21Y/Y Change
Revenue
246.2M
↑ 26.34%
Net Income
71.4M
↑ 1135.01%
Net Profit Margin
28.99%
↑ 26.02%
FY22Y/Y Change
Revenue
270.7M
↑ 9.91%
Net Income
120.8M
↑ 69.2%
Net Profit Margin
44.63%
↑ 15.64%
FY23Y/Y Change
Revenue
325.1M
↑ 20.12%
Net Income
-81.1M
↓ 167.13%
Net Profit Margin
-24.95%
↓ 69.58%
Q4 FY22Q/Q Change
Revenue
74.0M
↑ 3.27%
Net Income
7.1M
↓ 71.79%
Net Profit Margin
9.56%
↓ 25.45%
Q1 FY23Q/Q Change
Revenue
74.0M
↑ 0.0%
Net Income
7.1M
↑ 0.0%
Net Profit Margin
9.56%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
76.7M
↑ 3.6%
Net Income
-32.3M
↓ 557.02%
Net Profit Margin
-42.18%
↓ 51.74%
Q3 FY23Q/Q Change
Revenue
84.2M
↑ 9.77%
Net Income
6.5M
↓ 120.09%
Net Profit Margin
7.72%
↑ 49.9%
Q4 FY23Q/Q Change
Revenue
93.0M
↑ 10.49%
Net Income
-14.6M
↓ 325.34%
Net Profit Margin
-15.75%
↓ 23.47%
Q1 FY24Q/Q Change
Revenue
89.6M
↓ 3.69%
Net Income
-71.4M
↑ 387.28%
Net Profit Margin
-79.67%
↓ 63.92%
FY19Y/Y Change
Total Assets
280.2M
-
Total Liabilities
221.4M
-
FY20Y/Y Change
Total Assets
364.4M
↑ 30.03%
Total Liabilities
300.6M
↑ 35.76%
FY21Y/Y Change
Total Assets
339.8M
↓ 6.75%
Total Liabilities
413.1M
↑ 37.44%
FY22Y/Y Change
Total Assets
403.3M
↑ 18.69%
Total Liabilities
329.4M
↓ 20.26%
FY23Y/Y Change
Total Assets
540.4M
↑ 34.0%
Total Liabilities
506.2M
↑ 53.66%
Q4 FY22Q/Q Change
Total Assets
403.3M
↑ 14.41%
Total Liabilities
329.4M
↑ 12.42%
Q1 FY23Q/Q Change
Total Assets
403.3M
↑ 0.0%
Total Liabilities
329.4M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
425.9M
↑ 5.6%
Total Liabilities
408.3M
↑ 23.95%
Q3 FY23Q/Q Change
Total Assets
476.9M
↑ 11.99%
Total Liabilities
439.0M
↑ 7.51%
Q4 FY23Q/Q Change
Total Assets
540.4M
↑ 13.3%
Total Liabilities
506.2M
↑ 15.3%
Q1 FY24Q/Q Change
Total Assets
529.1M
↓ 2.08%
Total Liabilities
555.8M
↑ 9.81%
FY19Y/Y Change
Operating Cash Flow
16.1M
-
Investing Cash Flow
-46.7M
-
Financing Cash Flow
75.5M
-
FY20Y/Y Change
Operating Cash Flow
66.5M
↑ 312.26%
Investing Cash Flow
-6.4M
↓ 86.2%
Financing Cash Flow
-8.6M
↓ 111.38%
FY21Y/Y Change
Operating Cash Flow
36.1M
↓ 45.79%
Investing Cash Flow
45.2M
↓ 801.29%
Financing Cash Flow
-68.4M
↑ 695.96%
FY22Y/Y Change
Operating Cash Flow
20.6M
↓ 42.92%
Investing Cash Flow
-91.2M
↓ 301.72%
Financing Cash Flow
14.0M
↓ 120.42%
Q4 FY22Q/Q Change
Operating Cash Flow
35.7M
↓ 6528.6%
Investing Cash Flow
-37.4M
↑ 217.42%
Financing Cash Flow
2.0M
↓ 72.81%
Q1 FY23Q/Q Change
Operating Cash Flow
35.7M
↑ 0.0%
Investing Cash Flow
-10.7M
↓ 71.31%
Financing Cash Flow
2.0M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
16.6M
↓ 53.62%
Investing Cash Flow
-10.7M
↑ 0.0%
Financing Cash Flow
5.7M
↑ 186.74%
Q3 FY23Q/Q Change
Operating Cash Flow
29.2M
↑ 76.03%
Investing Cash Flow
-10.9M
↑ 1.42%
Financing Cash Flow
8.8M
↑ 54.97%

Technicals Summary

Sell

Neutral

Buy

Cellebrite Di Ltd. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cellebrite Di Ltd.
Cellebrite Di Ltd.
16.1%
48.11%
77.69%
33.66%
33.66%
Microsoft Corporation
Microsoft Corporation
-7.47%
3.58%
23.87%
44.75%
196.02%
Palo Alto Networks, Inc.
Palo Alto Networks, Inc.
-1.58%
-6.52%
30.66%
140.71%
323.02%
Adobe Systems Inc.
Adobe Systems Inc.
0.66%
-13.32%
3.42%
-14.28%
70.96%
Oracle Corp.
Oracle Corp.
-0.3%
20.22%
19.32%
56.86%
135.59%
Synopsys Inc.
Synopsys Inc.
-9.99%
2.01%
19.89%
89.76%
292.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cellebrite Di Ltd.
Cellebrite Di Ltd.
69.09
NA
NA
0.33
-17.69
0.06
NA
-0.14
Microsoft Corporation
Microsoft Corporation
37.17
37.17
2.24
11.81
0.38
0.15
0.01
34.06
Palo Alto Networks, Inc.
Palo Alto Networks, Inc.
47.01
47.01
1.12
5.57
0.86
0.03
NA
13.82
Adobe Systems Inc.
Adobe Systems Inc.
47.84
47.84
1.76
18.17
0.34
0.16
NA
33.06
Oracle Corp.
Oracle Corp.
37.4
37.4
1.02
5.59
1.94
0.07
0.01
3.16
Synopsys Inc.
Synopsys Inc.
60.26
60.26
2.6
13.08
0.22
0.09
NA
46.69
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cellebrite Di Ltd.
Cellebrite Di Ltd.
Buy
$2.7B
33.66%
69.09
-33.98%
Microsoft Corporation
Microsoft Corporation
Buy
$3.2T
196.02%
37.17
36.43%
Palo Alto Networks, Inc.
Palo Alto Networks, Inc.
Buy
$105.0B
323.02%
47.01
31.42%
Adobe Systems Inc.
Adobe Systems Inc.
Buy
$235.5B
70.96%
47.84
24.86%
Oracle Corp.
Oracle Corp.
Buy
$382.4B
135.59%
37.4
19.76%
Synopsys Inc.
Synopsys Inc.
Buy
$84.8B
292.97%
60.26
22.6%

Insights on Cellebrite Di Ltd.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 93.01M → 89.58M (in $), with an average decrease of 3.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 6.5M → -71.37M (in $), with an average decrease of 356.3% per quarter

Institutional Holdings

  • Igp Investments (GPLP) Lp

    10.27%

  • True Wind Capital Management, L.P.

    6.52%

  • Clal Insurance Enterprises Holdings Ltd

    2.96%

  • Morgan Stanley - Brokerage Accounts

    2.01%

  • Crosslink Capital Inc

    1.75%

  • Nine Ten Capital Management LLC

    1.69%

Company Information

Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data.

Organization
Cellebrite Di Ltd.
Employees
1008
CEO
Mr. Yossi Carmil
Industry
Technology

Discover More

FAQs